NE ED90 Bolus in C-Sec

Launched by PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE · Aug 25, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating the right dose of a medication called norepinephrine to help maintain stable blood pressure in women undergoing elective cesarean sections. When spinal anesthesia is given for this type of surgery, some patients may experience a drop in blood pressure. The goal of the study is to find out how much norepinephrine needs to be given initially to prevent a significant drop in blood pressure after the anesthesia is administered.

To participate in this study, women must be between 18 and 40 years old, be healthy with no serious pregnancy-related health issues, and be scheduled for a cesarean section. Some women may not be eligible if they have high blood pressure disorders, heart disease, or certain other medical conditions. Participants can expect to receive the medication during their surgery and will be monitored for their blood pressure and overall health. This trial is not yet recruiting participants, but it aims to help improve the safety of cesarean deliveries.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Full-term singleton pregnant patients
• • ASA II or III
• • Scheduled for elective cesarean section
• • Age between 18 and 40 years.
• Exclusion Criteria:
• • Hypertensive disorders of pregnancy
• • Cardiovascular disease
• • Baseline systolic BP \<100 mmHg
• • Height less than 145 cm or greater than 180 cm
• • Weight less than 40 kg or greater than 100 kg
• • Need for uterine exteriorization during surgery
• • Coagulation disorders.